NSF provides more support for drug discovery platform to create options for hard-to-treat cancers
A new round of support will help a Purdue University-affiliated startup further develop a platform designed to create drugs for people with hard-to-treat cancers. Akanocure Pharmaceuticals Inc. has received a $750,000 Small Business Innovation Research Phase II grant from the National Science Foundation to develop chemical tools and platforms to produce valuable chemical building blocks.